These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 30966075)

  • 1. Polymer-Based Nanomaterials and Applications for Vaccines and Drugs.
    Han J; Zhao D; Li D; Wang X; Jin Z; Zhao K
    Polymers (Basel); 2018 Jan; 10(1):. PubMed ID: 30966075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of biodegradable nanomaterials and applications in vaccines.
    Yan X; Zhou M; Yu S; Jin Z; Zhao K
    Vaccine; 2020 Jan; 38(5):1096-1104. PubMed ID: 31813649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of polymeric nanoparticles-based vaccine].
    Akagi T; Akashi M
    Nihon Rinsho; 2006 Feb; 64(2):279-85. PubMed ID: 16454182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
    Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
    Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
    Sharma R; Agrawal U; Mody N; Vyas SP
    Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine].
    Akagi T; Baba M; Akashi M
    Yakugaku Zasshi; 2007 Feb; 127(2):307-17. PubMed ID: 17268151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles as carriers for nasal vaccine delivery.
    Köping-Höggård M; Sánchez A; Alonso MJ
    Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of nanoparticles/microparticles in mucosal vaccine delivery.
    Vyas SP; Gupta PN
    Expert Rev Vaccines; 2007 Jun; 6(3):401-18. PubMed ID: 17542755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications and perspectives of nanomaterials in novel vaccine development.
    Shen Y; Hao T; Ou S; Hu C; Chen L
    Medchemcomm; 2018 Feb; 9(2):226-238. PubMed ID: 30108916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of nanomaterials as vaccine adjuvants.
    Zhu M; Wang R; Nie G
    Hum Vaccin Immunother; 2014; 10(9):2761-74. PubMed ID: 25483497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles and Vaccine Development.
    Kheirollahpour M; Mehrabi M; Dounighi NM; Mohammadi M; Masoudi A
    Pharm Nanotechnol; 2020; 8(1):6-21. PubMed ID: 31647394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.
    Pippa N; Gazouli M; Pispas S
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acids presenting polymer nanomaterials as vaccine adjuvants.
    Comberlato A; Paloja K; Bastings MMC
    J Mater Chem B; 2019 Nov; 7(41):6321-6346. PubMed ID: 31460563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy.
    Mao L; Ma P; Luo X; Cheng H; Wang Z; Ye E; Loh XJ; Wu YL; Li Z
    ACS Nano; 2023 Jun; 17(11):9826-9849. PubMed ID: 37207347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.
    Gutjahr A; Phelip C; Coolen AL; Monge C; Boisgard AS; Paul S; Verrier B
    Vaccines (Basel); 2016 Oct; 4(4):. PubMed ID: 27754314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview.
    Kaur L; Sharma A; Yadav AK; Mishra N
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):452-464. PubMed ID: 28685588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.